Silvercrest Asset Management Group LLC Sells 1,574 Shares of Simulations Plus, Inc. (NASDAQ:SLP)

Silvercrest Asset Management Group LLC decreased its stake in shares of Simulations Plus, Inc. (NASDAQ:SLP) by 1.0% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 159,759 shares of the technology company’s stock after selling 1,574 shares during the period. Silvercrest Asset Management Group LLC owned 0.80% of Simulations Plus worth $4,456,000 as of its most recent filing with the SEC.

Other institutional investors have also recently bought and sold shares of the company. Jones Financial Companies Lllp boosted its holdings in Simulations Plus by 53.6% in the 4th quarter. Jones Financial Companies Lllp now owns 1,223 shares of the technology company’s stock valued at $34,000 after purchasing an additional 427 shares during the period. Johnson Financial Group Inc. acquired a new position in shares of Simulations Plus in the 4th quarter valued at approximately $39,000. Tower Research Capital LLC TRC raised its position in shares of Simulations Plus by 42.2% in the 4th quarter. Tower Research Capital LLC TRC now owns 2,575 shares of the technology company’s stock valued at $72,000 after buying an additional 764 shares in the last quarter. AlphaQuest LLC raised its position in shares of Simulations Plus by 502.9% in the 4th quarter. AlphaQuest LLC now owns 2,689 shares of the technology company’s stock valued at $75,000 after buying an additional 2,243 shares in the last quarter. Finally, KLP Kapitalforvaltning AS acquired a new position in shares of Simulations Plus in the 4th quarter valued at approximately $86,000. Institutional investors own 78.08% of the company’s stock.

Simulations Plus Stock Performance

Shares of NASDAQ:SLP opened at $31.33 on Tuesday. The company has a fifty day moving average of $29.15 and a 200-day moving average of $30.31. The company has a market capitalization of $630.08 million, a PE ratio of 78.33 and a beta of 1.10. Simulations Plus, Inc. has a 52-week low of $23.01 and a 52-week high of $50.98.

Simulations Plus (NASDAQ:SLP) last announced its quarterly earnings results on Thursday, April 3rd. The technology company reported $0.31 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.25 by $0.06. The company had revenue of $22.43 million during the quarter, compared to the consensus estimate of $21.93 million. Simulations Plus had a net margin of 10.97% and a return on equity of 6.84%. The company’s revenue for the quarter was up 22.5% compared to the same quarter last year. During the same period in the prior year, the business earned $0.20 earnings per share. On average, equities analysts forecast that Simulations Plus, Inc. will post 1.09 EPS for the current fiscal year.

Insider Transactions at Simulations Plus

In related news, Director Walter S. Woltosz sold 20,000 shares of the business’s stock in a transaction on Thursday, May 1st. The shares were sold at an average price of $33.51, for a total value of $670,200.00. Following the sale, the director now owns 3,344,157 shares of the company’s stock, valued at $112,062,701.07. The trade was a 0.59% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Company insiders own 19.40% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts have recently commented on SLP shares. StockNews.com upgraded shares of Simulations Plus from a “sell” rating to a “hold” rating in a research report on Monday, April 28th. KeyCorp boosted their target price on shares of Simulations Plus from $32.00 to $40.00 and gave the company an “overweight” rating in a research report on Wednesday, April 16th. Two analysts have rated the stock with a hold rating, five have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $50.00.

Simulations Plus Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.